Pharma has long marketed opioids in ways that contribute to opioid use disorder and deaths by overdose. Regulatory mistakes in approving and labeling new analgesics by the FDA didn’t make us safer.
AMA J Ethics. 2020;22(8):E743-750. doi:
10.1001/amajethics.2020.743.
Despite industry regulations for pharmaceutical speaker programming at restaurants, pharmaceutical representatives, compliance companies, and restaurants lack incentives for ensuring compliance with guidelines.
AMA J Ethics. 2015;17(8):787-795. doi:
10.1001/journalofethics.2015.17.8.sect1-1508.